TissGeneSummary for ZNF571 |
Gene summary |
Basic gene information | Gene symbol | ZNF571 |
Gene name | zinc finger protein 571 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 19q13.12 | |
Type of gene | protein-coding | |
RefGenes | NM_001290314.1, NM_016536.4, | |
Description | - | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000180479 | ||
HPRD : 15850 | ||
Vega : OTTHUMG00000182016 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ZNF571 | |
BioGPS: 51276 | ||
Pathway | NCI Pathway Interaction Database: ZNF571 | |
KEGG: ZNF571 | ||
REACTOME: ZNF571 | ||
Pathway Commons: ZNF571 | ||
Context | iHOP: ZNF571 | |
ligand binding site mutation search in PubMed: ZNF571 | ||
UCL Cancer Institute: ZNF571 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | TestisThyroid gland | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCTTHCA | |
Reference showing the relevant tissue of ZNF571 | ||
Description by TissGene annotations | TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for ZNF571 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
HNSC | -1.625089025 | -0.619816932 | -1.005272093 | 3.64E-05 | 0.000181195 |
Top |
TissGene-miRNA for ZNF571 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for ZNF571 |
TissGeneSNV for ZNF571 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.H465Y | LGG | 1 |
p.R243I | READ | 1 |
p.T553N | BRCA | 1 |
p.W70* | SKCM | 1 |
p.E192K | HNSC | 1 |
p.R569C | LUAD | 1 |
p.G453* | LUAD | 1 |
p.R130W | LIHC | 1 |
p.C284R | UCEC | 1 |
p.G554A | BLCA | 1 |
p.G526C | BRCA | 1 |
p.K55M | STAD | 1 |
p.E451V | SKCM | 1 |
p.E451K | LUAD | 1 |
p.T267S | STAD | 1 |
p.S126F | ESCA | 1 |
p.S152L | STAD | 1 |
p.K392T | UCEC | 1 |
p.L573H | COAD | 1 |
p.E240Q | STAD | 1 |
p.K432N | LUAD | 1 |
p.E252D | COAD | 1 |
p.A227T | PRAD | 1 |
p.N162Y | LIHC | 1 |
p.R76C | BLCA | 1 |
p.A26V | UCEC | 1 |
p.G128E | SARC | 1 |
p.N72H | COAD | 1 |
p.R550I | UCEC | 1 |
p.R494I | COAD | 1 |
p.M108V | STAD | 1 |
p.K533T | LUAD | 1 |
p.D508V | LUAD | 1 |
p.Y223H | LUAD | 1 |
p.C368Y | UCEC | 1 |
p.R411I | UCS | 1 |
p.R411I | STAD | 1 |
p.E100X | COAD | 1 |
p.E555D | BRCA | 1 |
p.G564V | STAD | 1 |
p.H441D | BLCA | 1 |
p.G105R | BLCA | 1 |
p.H469N | READ | 1 |
p.R541H | UCEC | 1 |
p.E252A | PRAD | 1 |
p.N56T | ESCA | 1 |
p.S123* | LUAD | 1 |
p.Q189H | COAD | 1 |
p.C597Y | LGG | 1 |
p.G369V | UCS | 1 |
p.R355I | UCEC | 1 |
p.S543X | ESCA | 1 |
p.S50T | PRAD | 1 |
p.E499K | CESC | 1 |
p.E475Q | LUAD | 1 |
p.R234C | SKCM | 1 |
p.P133S | SKCM | 1 |
p.C144R | UCS | 1 |
p.R389K | COAD | 1 |
Top |
TissGeneCNV for ZNF571 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for ZNF571 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for ZNF571 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for ZNF571 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for ZNF571 |
TissGeneDrug for ZNF571 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for ZNF571 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |